Scientific Management Team

The composition of the Scientific Management Team (SMT) reflects the involvement of different stakeholders in VAC2VAC. Companies developing human vaccines are represented by two of the leading European companies: Sanofi Pasteur and GlaxoSmithKline Biologicals, whereas companies developing veterinary vaccines are represented by Zoetis. Intravacc  represents the public research organisations participating in VAC2VAC.

The SMT will work collegially to ensure strong scientific leadership and is responsible for the strategic direction of the activities and for the overall scientific oversight of the project.